Pyrotinib as a therapeutic for HER2-positive breast cancer
Transl Cancer Res
.
2023 Jun 30;12(6):1376-1379.
doi: 10.21037/tcr-23-333.
Epub 2023 Jun 1.
Authors
Ivelina Kioutchoukova
1
,
Brandon P Lucke-Wold
2
Affiliations
1
College of Medicine, University of Florida, Gainesville, Florida, USA.
2
Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.
PMID:
37434682
PMCID:
PMC10331451
DOI:
10.21037/tcr-23-333
No abstract available
Keywords:
Pyrotinib; breast cancer; commentary; human epidermal growth factor receptor 2 (HER2).
Publication types
Editorial
Comment